Module 4: Principles of Drug Metabolism and Toxicokinetics and Applications to Pharmaceutical Toxicology
Recorded On: 08/05/2021
This lecture explains the basic concepts of absorption, distribution, metabolism, and excretion (ADME) of both small and large molecules. It focuses on toxicokinetic parameters such as Tmax, Cmax, and area under the curve (AUC), bioavailability, and volume of distribution. Various factors that affect ADME parameters, such as physicochemical properties of chemicals, storage depots, drug-metabolizing enzymes, metabolism by intestinal microflora, and elimination kinetics, are discussed. Additionally, monoclonal antibody disposition, distribution, and clearance are also discussed. The application of toxicokinetics in the interpretation of toxicological findings, scaling in dose-response extrapolation, and determining the margin of safety (MOS) is explained using specific examples. Further, characterization of disproportionate metabolites and their safety assessment is discussed. Finally, physiologically based pharmacokinetic modeling capable of accommodating more complex dosing regimens is addressed.
Debie J. Hoivik, PhD, DABT
Vice President of Early Development
Akebia Therapeutics, Inc.
Dr. Debie Hoivik received her PhD in toxicology from the University of Connecticut and conducted her postdoctoral research at Texas A&M. Since then, she has spent over the last 25 years as a regulatory toxicologist in the pharmaceutical industry (GlaxoSmithKline and Boehringer-Ingelheim), where she was responsible for the nonclinical product development strategy and execution as well as regulatory interactions and submissions for new therapeutic entities. Dr. Hoivik is currently Vice President, Early Development at Akebia Therapeutics, where she is the Program Executive for programs in the Discovery to Clinical Proof of Concept phase of development, as well as having accountability for the toxicology and DMPK disciplines. Dr. Hoivik has authored five invited book chapters, and over 50 manuscripts and abstracts. She has served ACT in a variety of roles (e.g., Councilor, Secretary, Continuing Education Committee, Nominating Committee, Program Committee); she has also been Chair of the SOT Education Committee and served on the SOT Communication Committee; and President of the Northeast Society of Toxicology. Dr. Hoivik has also served on multiple pharmaceutical consortiums and workgroups. She has been a member of the Editorial Review Board for the International Journal of Toxicology and served as a reviewer for Toxicological Sciences. Dr. Hoivik was certified by the American Board of Toxicology in 1999.